Jeffrey Skolnick, PhD profile page

Jeffrey Skolnick is a Regents’ Professor and the Director of the Center for the Study of Systems Biology in the School of Biological Sciences at the Georgia Institute of Technology. He is also the Thrust Lead for Precision Medicine and Drug Discovery un the Institute for Data Engineering and Science (IDEaS). He is the Mary and Maisie Gibson Chair in Computational Systems Biology and a Georgia Research Alliance Eminent Scholar in Computational Systems Biology. He is also the Chief Scientific Officer of the Ovarian Cancer Institute. He attended graduate school in Chemistry at Yale, receiving a Ph.D. in Chemistry. He then held a postdoctoral fellowship at Bell Laboratories. Next, he joined the faculty of the Chemistry Department at Louisiana State University, Baton Rouge. Then, he moved to Washington University. Following his emerging interest in biology, he joined the Department of Molecular Biology of the Scripps Research Institute, where he held the rank of Professor. Among his awards are the Southeastern Universities Research Association (SURA) Distinguished Scientist Award, the Sigma Xi Sustained Research Award, and an Alfred P. Sloan Research Fellowship. He is a Fellow of the AAAS, the Biophysical Society, and the St. Louis Academy of Science. He is the author of over 415 publications, has an h-index of 96 and has served on 21 editorial boards. Dr. Skolnick’s current research interests are in computational biology and bioinformatics. He has developed AI based approaches to predict disease mode of action proteins, drug efficacy and side effects, diagnostic tools to identify early-stage cancers and a non- Mendelian approach to precision medicine. He has applied these tools to aging, cancer, chronic fatigue syndrome and cancer metabolomics. He has also done substantial research on the possible origins of the biochemistry of life.